Isolated cavernous sinus extramedullary relapse of chronic myelogenous leukemia following allogeneic stem cell transplant

Author： Martel C.   Reddy S.   Greco C.   Tuscano J.   Richman C.   Wun T.  

Publisher： Springer Publishing Company

ISSN： 0939-5555

Source： Annals of Hematology, Vol.81, Iss.2, 2002-02, pp. : 108-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant - reagents for tumor immunology

By Dazzi F.   Szydlo R.M.   Goldman J.M.  

Experimental Hematology, Vol. 27, Iss. 10, 1999-10 ,pp. : 1477-1486

Elsevier

Access to resources Recommend Favorite

Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

By Slavin S.   Nagler A.   Varadi G.   Or R.  

Experimental Hematology, Vol. 28, Iss. 7, 2000-07 ,pp. : 853-857

Elsevier

Access to resources Recommend Favorite

Allogeneic transplantation for chronic myelogenous leukemia

By McGlave Philip  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 15-18

Maney Publishing

Access to resources Recommend Favorite

Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation

By Cho Byung-Sik   Lim Ji-Young   Yahng Seung-Ah   Lee Sung-Eun   Eom Ki-Seong   Kim Yoo-Jin   Chung Nak-Gyun   Jeong Dae-Chul   Lee Seok   Kim Hee-Je   Cho Seok-Goo   Kim Dong-Wook   Lee Jong-Wook   Min Woo-Sung   Park Chong-Won   Min Chang-Ki  

Annals of Hematology, Vol. 91, Iss. 3, 2012-03 ,pp. : 439-448

Springer Publishing Company

Access to resources Recommend Favorite

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3+ and CD4+ lymphocytes

By Vela-Ojeda J.   García-Ruiz Esparza M.   Reyes-Maldonado E.   Jiménez-Zamudio L.   Moreno-Lafont M.   García-Latorre E.   Ramírez-Sanjuan E.   Montiel-Cervantes L.   Tripp-Villanueva F.   García-León L.   Ayala-Sánchez M.   Rosas-Cabral A.   Aviña-Zubieta J.   Galindo-Rodríguez G.   Vadillo-Buenfil M.   Salazar-Exaire D.  

Annals of Hematology, Vol. 83, Iss. 5, 2004-05 ,pp. : 295-301

Springer Publishing Company

Access to resources Recommend Favorite